Also known as: Corza Medical GmbH
Highest phase reached
Phase 3
First clinical trial
First marketed drug
Last known activity
Nov 25, 2024
2010s
human fibrin— NDA Secondary Org
Phase 3 (2 own, 0 via acquisition)